Items where Author is "Davis, Courtney"

Article

Cherla, Avi, Davis, Courtney, Mossialos, Elias ORCID: 0000-0001-8664-9297 and Naci, Huseyin (2023) Faster UK drug approvals by relying on other countries. BMJ (Clinical research ed.), 381. p. 739. ISSN 1756-1833

Davis, Courtney, Wagner, Anita K., Salcher-Konrad, Maximilian ORCID: 0000-0002-5628-5266, Scowcroft, Henry, Mintzes, Barbara, Pokorny, Adrian M J, Lew, Jianhui and Naci, Huseyin (2023) Communication of anticancer drug benefits and related uncertainties to patients and clinicians: document analysis of regulated information on prescription drugs in Europe. BMJ, 380. e073711. ISSN 0959-8138

Salcher-Konrad, Maximilian ORCID: 0000-0002-5628-5266, Naci, Huseyin and Davis, Courtney (2020) Approval of cancer drugs with uncertain therapeutic value: a comparison of regulatory decisions in Europe and the United States. Milbank Quarterly, 98 (4). 1219 - 1256. ISSN 0887-378X

Naci, Huseyin, Davis, Courtney, Savović, Jelena, Higgins, Julian P. T., Sterne, Jonathan, Gyawali, Bishal, Romo Sandoval, Xochitl Citlalli, Handley, Nicola and Booth, Christopher M (2019) Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross-sectional analysis. BMJ, 366 (8214). ISSN 1756-1833

Davis, Courtney, Naci, Huseyin, Gurpinar, Evrim, Poplavska, Elita, Pinto, Ashlyn and Aggarwal, Ajay (2017) Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13. BMJ (359). ISSN 1756-1833